Lisa DeFrancesco - Feb 28, 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, IR and Corp Comm
Signature
/s/ Lisa M. DeFrancesco
Stock symbol
LXRX
Transactions as of
Feb 28, 2025
Transactions value $
-$6,094
Form type
4
Date filed
3/3/2025, 04:30 PM
Previous filing
Feb 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +24.7K 24.7K Feb 28, 2025 Direct F1
transaction LXRX Common Stock Tax liability -$6.09K -9.1K -36.87% $0.67 15.6K Feb 28, 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -24.7K -33.33% 49.3K Feb 28, 2025 Common Stock 24.7K Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Each restricted stock unit represents a contingent right to receive one share of common stock.
F4 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.